Acadia Pharmaceuticals has hired Big Pharma veteran Thomas Andrew Garner as its new chief commercial officer (CCO). The company is looking to consolidate its older drug, Nuplazid, while boosting its ...

Acadia Pharmaceuticals (ACAD) announced that Thomas Andrew Garner has been appointed Chief Commercial Officer, effective today. Mr. Garner will spearhead Acadia’s commercial strategy and operations, ...

Acadia Realty Trust’s fourth-quarter earnings remained relatively stagnant compared to previous times, but that hasn’t changed the company’s focus on expanding its street retail across the U.S. Acadia ...

Looking at the universe of stocks we cover at Dividend Channel, on 12/29/14, Apollo Commercial Real Estate Finance Inc. (NYSE: ARI), Acadia Realty Trust (NYSE: AKR), and Pembina Pipeline Corp (NYSE: ...

A little-known Westchester-based real estate investor is continuing its Manhattan shopping spree into the new year with its latest acquisition, a $25 million purchase in SoHo, records show. Acadia ...

Acadia Realty Trust is continuing its Upper East Side push with the purchase of a five-story commercial building at 801 Madison Avenue for $33 million, according to property records filed with the ...